{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:42:47Z","timestamp":1786984967319,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R03 AI142273"],"award-info":[{"award-number":["R03 AI142273"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R56 DE023838"],"award-info":[{"award-number":["R56 DE023838"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01 DE030646"],"award-info":[{"award-number":["R01 DE030646"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R03 DE028033"],"award-info":[{"award-number":["R03 DE028033"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bbadis.2021.166302","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T11:11:00Z","timestamp":1636715460000},"page":"166302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Plasmacytoid dendritic cells promote the pathogenesis of Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"1868","author":[{"given":"Jing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2021.166302_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1196\/annals.1384.003","article-title":"Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy","volume":"1098","author":"Fox","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2021.166302_bb0010","first-page":"11742","article-title":"T cell-associated cytokines in the pathogenesis of Sjogren's syndrome","volume":"S!(9)","author":"Jin","year":"2013","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00005-009-0002-4","article-title":"Sjogren's syndrome: an old tale with a new twist","volume":"57","author":"Lee","year":"2009","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.bbadis.2021.166302_bb0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrrheum.2010.118","article-title":"Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome","volume":"6","author":"Voulgarelis","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/eci.12.106","article-title":"Fueling autoimmunity: type I interferon in autoimmune diseases","volume":"9","author":"Di Domizio","year":"2013","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.autrev.2012.10.006","article-title":"Type I interferons in Sjogren's syndrome","volume":"12","author":"Yao","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbadis.2021.166302_bb0035","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.20998","article-title":"Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism","volume":"52","author":"Bave","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2021.166302_bb0040","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0022034513483315","article-title":"Type I interferon receptor deficiency prevents murine Sjogren's syndrome","volume":"92","author":"Szczerba","year":"2013","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bbadis.2021.166302_bb0045","first-page":"212","article-title":"Pivotal functions of plasmacytoid dendritic cells in systemic autoimmune pathogenesis","volume":"5","author":"Cao","year":"2014","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0050","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2021.166302_bb0055","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/eji.200738008","article-title":"Systemic increase in type I interferon activity in Sjogren's syndrome: a putative role for plasmacytoid dendritic cells","volume":"38","author":"Wildenberg","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0060","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2021.166302_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fimmu.2013.00059","article-title":"Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity","volume":"4","author":"Guery","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","article-title":"Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history","volume":"19","author":"Fitzgerald-Bocarsly","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbadis.2021.166302_bb0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coi.2016.10.006","article-title":"Plasmacytoid dendritic cells in autoimmunity","volume":"44","author":"Panda","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0080","doi-asserted-by":"crossref","first-page":"24477","DOI":"10.1038\/srep24477","article-title":"Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation","volume":"6","author":"Takagi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2021.166302_bb0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2021.166302_bb0090","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.4049\/jimmunol.1201897","article-title":"In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells","volume":"190","author":"Ioannou","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0100","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20132620","article-title":"Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model","volume":"211","author":"Rowland","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2021.166302_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2011.04.010","article-title":"The role of interferon alpha in initiation of type I diabetes in the NOD mouse","volume":"140","author":"Li","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.0105-2896.2009.00881.x","article-title":"Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance","volume":"234","author":"Swiecki","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbadis.2021.166302_bb0115","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3389\/fimmu.2019.02096","article-title":"Plasmacytoid DCs from patients with Sjogren's syndrome are transcriptionally primed for enhanced pro-inflammatory cytokine production","volume":"10","author":"Hillen","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0120","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/art.38007","article-title":"Interleukin-7 enhances the Th1 response to promote the development of Sjogren's syndrome-like autoimmune exocrinopathy in mice","volume":"65","author":"Jin","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2021.166302_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077605","article-title":"Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjogren's syndrome in a mouse model","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2021.166302_bb0130","doi-asserted-by":"crossref","first-page":"39105","DOI":"10.1038\/srep39105","article-title":"Endogenous programmed death ligand-1 restrains the development and onset of Sjgren's syndrome in non-obese diabetic mice","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2021.166302_bb0135","first-page":"2438","article-title":"Anti-IL-7 receptor-alpha treatment ameliorates newly established Sjogren's-like exocrinopathy in non-obese diabetic mice","volume":"2018","author":"Zhou","year":"1864","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2021.166302_bb0140","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41374-017-0013-4","article-title":"Disruption of CXCR3 function impedes the development of Sjogren's syndrome-like xerostomia in non-obese diabetic mice","volume":"98","author":"Zhou","year":"2018","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2021.166302_bb0145","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/labinvest.2016.141","article-title":"Pathogenic role of endogenous TNF-alpha in the development of Sjogren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice","volume":"97","author":"Zhou","year":"2017","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2021.166302_bb0150","article-title":"Current concepts: mouse models of Sjogren's syndrome","volume":"2011","author":"Lavoie","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-59745-395-0_17","article-title":"Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse","volume":"380","author":"Giarratana","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0160","first-page":"2438","article-title":"Anti-IL-7 receptor-alpha treatment ameliorates newly established Sjogren's-like exocrinopathy in non-obese diabetic mice","volume":"2018","author":"Zhou","year":"1864","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbadis.2021.166302_bb0165","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1167\/iovs.15-17368","article-title":"Innate immune signaling induces IL-7 production, early inflammatory responses, and Sjogren's-like dacryoadenitis in C57BL\/6 mice","volume":"56","author":"Zhou","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbadis.2021.166302_bb0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2021.166302_bb0175","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/rheumatology\/kev420","article-title":"Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjogren's syndrome","volume":"55","author":"Thompson","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbadis.2021.166302_bb0180","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/eji.200738013","article-title":"Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways","volume":"38","author":"Ittah","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0185","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/annrheumdis-2018-213929","article-title":"Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD\/ShiLtJ mouse model of Sjogren's syndrome","volume":"78","author":"Wieczorek","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbadis.2021.166302_bb0190","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.4049\/jimmunol.1001520","article-title":"A role for lymphotoxin in primary Sjogren's disease","volume":"185","author":"Shen","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0195","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.0300-9475.2004.01508.x","article-title":"A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse","volume":"60","author":"Cha","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/0394632016651273","article-title":"A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjogren's syndrome","volume":"29","author":"Benchabane","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0205","article-title":"Emerging roles for chemokines and cytokines as orchestrators of immunopathology in Sjogren's syndrome","author":"Blokland","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbadis.2021.166302_bb0210","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.4049\/jimmunol.179.8.5041","article-title":"The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse","volume":"179","author":"Saxena","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0215","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.4049\/jimmunol.1101855","article-title":"Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells","volume":"189","author":"Sawant","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0220","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.4049\/jimmunol.177.5.3260","article-title":"Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation","volume":"177","author":"Blasius","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.rdc.2016.03.002","article-title":"Autoantibodies in Sjogren's syndrome","volume":"42","author":"Fayyaz","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.bbadis.2021.166302_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/465898","article-title":"Anti-TNF-alpha therapies in systemic lupus erythematosus","volume":"2010","author":"Zhu","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bbadis.2021.166302_bb0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1874312901206010315","article-title":"Anti-tumor necrosis factor-alpha induced systemic lupus erythematosus\u00a7","volume":"6","author":"Almoallim","year":"2012","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.bbadis.2021.166302_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf8442","article-title":"Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus","volume":"13","author":"Karnell","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2021.166302_bb0245","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI124466","article-title":"Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus","volume":"129","author":"Furie","year":"2019","journal-title":"J. Clin. Invest."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443921002350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443921002350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:05:29Z","timestamp":1760418329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443921002350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0925443921002350"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2021.166302","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmacytoid dendritic cells promote the pathogenesis of Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2021.166302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166302"}}